Evidence map›Paper›PMID 20971697›Full record

ArticleMagnesium research2010

The role of magnesium deficiency in cardiovascular and intestinal inflammation.

William B Weglicki, Iu Tong Mak, Joanna J Chmielinska, Maria Isabel Tejero-Taldo, Andrei M Komarov, Jay H Kramer

Abstract read
In one paragraph

Article in Magnesium research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Antioxidant/anti-inflammatory effect of MgReviews in medical virology · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

William B WeglickiDivision of Experimental Medicine, Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington, DC 20037, USA. phywbw@gwumc.edu
Iu Tong Mak
Joanna J Chmielinska
Maria Isabel Tejero-Taldo
Andrei M Komarov
Jay H Kramer
Washington University Medical Center · US

Funding

Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)R01HL065178 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2000 to 2007
$2.7M
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATIONR01HL062282 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI WEGLICKI, WILLIAM BERNARD · 2000 to 2007
$2.5M
NHLBI NIH HHS HL065178NHLBI NIH HHS R01 HL062282NHLBI NIH HHS R01 HL065178
6 · The paper itself

Abstract

Hypomagnesemia continues to cause difficult clinical problems, such as significant cardiac arrhythmias where intravenous magnesium therapy can be lifesaving. Nutritional deficiency of magnesium may present with some subtle symptoms such as leg cramps and occasional palpitation. We have investigated dietary-induced magnesium deficiency in rodent models to assess the pathobiology associated with prolonged hypomagnesemia. We found that neuronal sources of the neuropeptide, substance P (SP), contributed to very early prooxidant/proinflammatory changes during Mg deficiency. This neurogenic inflammation is systemic in nature, affecting blood cells, cardiovascular, intestinal, and other tissues, leading to impaired cardiac contractility similar to that seen in patients with heart failure. We have used drugs that block the release of SP from neurons and SP-receptor blockers to prevent some of these pathobiological changes; whereas, blocking SP catabolism enhances inflammation. Our findings emphasize the essential role of this cation in preventing cardiomyopathic changes and intestinal inflammation in a well-studied animal model, and also implicate the need for more appreciation of the potential clinical relevance of optimal magnesium nutrition and therapy.

Indexed as

AnimalsCardiovascular DiseasesHumansIntestinal MucosaIntestinesMagnesium DeficiencyReceptors, Neurokinin-1Substance PReceptors, Neurokinin-1Substance P

Identifiers

PMID20971697
PMCPMC3800093
OpenAlexW2140855929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.